Bliss GVS Pharma spurts on the BSE
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Bliss GVS Pharma is currently trading at Rs. 80.45, up by 2.60 points or 3.34% from its previous closing of Rs. 77.85 on the BSE.
The scrip opened at Rs. 76.45 and has touched a high and low of Rs. 82.10 and Rs. 75.60 respectively. So far 33828 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 190.00 on 05-Mar-2021 and a 52 week low of Rs. 77.00 on 21-Feb-2022.
Last one week high and low of the scrip stood at Rs. 91.45 and Rs. 75.60 respectively. The current market cap of the company is Rs. 844.46 crore.
The promoters holding in the company stood at 33.14%, while Institutions and Non-Institutions held 26.25% and 40.61% respectively.
Bliss GVS Pharma has received an approval of 'Certificate of GMP Compliance of a Manufacturer' from Therapeutic Goods Administration (TGA), Department of Health, Australia for its manufacturing unit situated at Plot no. 11, Survey no. 38/1, Dewan Udyog Nagar, Aliyali Village, District-Palghar, after an inspection.
Bliss GVS Pharma is engaged in the manufacture of a wide range of Pessary Formulations, Suppository Formulations, Calcium Preparation, Protein Powders, Iron Preparation, Antibiotics, Analgesic & Antipyretics, Respiratory, Anti-inflammatory, Dermatological Preparations, Anti-Diarrhoeal products.
